Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ENVB

Enveric Biosciences Inc

May 13 • 02:13PM ET

2.49

-0.03 -1.19 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: DRUG GHRS CMPS ATAI BIVI

| Held by: PSIL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-40.85	Insider Own	14.34%	Shs Outstand	1.99M	Perf Week	-21.70%
Market Cap	4.94M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.70M	Perf Month	27.69%
Enterprise Value	0.26M	PEG	-	EPS next Q	-	Inst Own	15.85%	Short Float	52.15%	Perf Quarter	18.01%
Income	-12.13M	P/S	-	EPS this Y	-	Inst Trans	7.34%	Short Ratio	0.21	Perf Half Y	-56.92%
Sales	0.00M	P/B	0.63	EPS next Y	-	ROA	-214.51%	Short Interest	0.89M	Perf YTD	-31.40%
Book/sh	3.94	P/C	1.06	EPS next 5Y	-	ROE	-304.04%	52W High	17.84 -86.04%	Perf Year	-85.45%
Cash/sh	2.36	P/FCF	-	EPS past 3/5Y	75.07% 67.96%	ROIC	-209.98%	52W Low	1.71 45.61%	Perf 3Y	-99.05%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	12.31% 24.56%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	84.04%	Oper. Margin	-	ATR (14)	0.67	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	5.33	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.84	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.33	EPS Q/Q	93.42%	SMA20	-30.13%	Beta	1.20	Target Price	1800.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-4.57%	Rel Volume	0.07	Prev Close	2.52
Employees	6	LT Debt/Eq	0.00	Earnings	Mar 27 BMO	SMA200	-59.04%	Avg Volume	4.20M	Price	2.49
IPO	Aug 22, 1995	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	224,739	Change	-1.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)